0001493152-20-012802.txt : 20200708 0001493152-20-012802.hdr.sgml : 20200708 20200708083434 ACCESSION NUMBER: 0001493152-20-012802 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200706 FILED AS OF DATE: 20200708 DATE AS OF CHANGE: 20200708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Golumbeski George CENTRAL INDEX KEY: 0001586660 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37348 FILM NUMBER: 201017308 MAIL ADDRESS: STREET 1: C/O CELGENE CORP. STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corbus Pharmaceuticals Holdings, Inc. CENTRAL INDEX KEY: 0001595097 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464348039 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 RIVER RIDGE DRIVE CITY: NORWOOD STATE: MA ZIP: 02062 BUSINESS PHONE: 617-963-0103 MAIL ADDRESS: STREET 1: 500 RIVER RIDGE DRIVE CITY: NORWOOD STATE: MA ZIP: 02062 FORMER COMPANY: FORMER CONFORMED NAME: SAV Acquisition Corp DATE OF NAME CHANGE: 20131220 4 1 ownership.xml X0306 4 2020-07-06 0 0001595097 Corbus Pharmaceuticals Holdings, Inc. CRBP 0001586660 Golumbeski George C/O CORBUS PHARMACEUTICALS HOLDINGS, INC. 500 RIVER RIDGE DRIVE SUMMIT NJ 07901 1 0 0 0 Stock Option(right to buy) 7.91 2020-07-06 4 A 0 81000 0.00 A 2030-07-06 Common Stock 81000 81000 D The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant. /s/ George Golumbeski 2020-07-08